In the initial study with SinoFresh Homeopathic Antiseptic Nasal Spray, SinoFresh HealthCare expects to assess symptom relief for chronic sinusitis sufferers.
SinoFresh is planning to conduct the trials by the end of the Q2 2011.
SinoFresh R&D vice president and chief pharmacist William Wilferth said SRS has extensive expertise in the design, conduct and evaluation of products like SinoFresh’s Nasal Spray and will be able to develop the data necessary for the company to inform users of the full benefits of SinoFresh Nasal Spray use.
SinoFresh CEO David Olund said they believe that success in these clinical initiatives has the potential to expand product usage, open additional markets and dramatically impact long term shareholder value," Wilferth said.